Increases share price. Its a way to return capital to shareholders.
Discussion
That’s the most charitable explanation.
The least charitable is that the management are incompetent capital allocators who have no clue how to productively spend the money on R&D and are looking to juice returns as fast as possible so they can get their bonus based on stock price performance then bounce to their next finacialization racket.
